stars 1 stars 2 stars 3

ImmunoVec is a biotechnology company with a novel platform using DNA-loaded polymeric nanoparticles to precisely reprogram cells in patients, offering the potential to reset the immune system and transform treatment for life-threatening autoimmune diseases, solid tumors, and genetic disorders. The company’s proprietary platform combines synthetic, cell type-specific promoters across multiple delivery vehicles to enable precise and durable expression of therapeutic payloads within targeted cells. ImmunoVec is headquartered in Los Angeles.

ImmunoVec Questions

Ryan Wong is the CEO of ImmunoVec.

8 people are employed at ImmunoVec.

ImmunoVec is based in Los Angeles, California.

Top ImmunoVec Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users